OpGen « Terug naar discussie overzicht

Curetis 2018

2.047 Posts, Pagina: « 1 2 3 4 5 6 ... 75 76 77 78 79 80 81 82 83 84 85 ... 99 100 101 102 103 » | Laatste

Omlaag ↓

nightrider 7 augustus 2018 13:51

oei, gemiddelde

nightrider 7 augustus 2018 13:53

Valt nog mee 4.85

nightrider 7 augustus 2018 13:55

De boot vertrekt. Hopelijk

j1954 7 augustus 2018 14:07

quote:
lucas D schreef op 7 augustus 2018 13:30:
Bedankt Noob nr1, heb het bericht verder nog nergens zien staan, maar dat zal niet lang meer duren.

Lucas even kijken op Finanzen.net , daar staan meerdere persberichten
op van Curetis.

joanb

MegaTelstar 7 augustus 2018 14:17

Volgens mij zijn de trossen al enkele uren geleden losgegooid. Ik ga pas winnen als de koers € 5,70 is gepasseerd, maar goed mijn verlies wordt rap minder... Ik zie een tweede freeze vanmiddag nog wel langskomen en dat met dit weer. It will overboil lijkt mij een betere term voor vandaag.
groet, SuperTelstar

lucas D 7 augustus 2018 14:21

quote:
joanwillem schreef op 7 augustus 2018 14:07:
[...]

Lucas even kijken op Finanzen.net , daar staan meerdere persberichten
op van Curetis.

joanb

Dank je Joanb.

j1954 7 augustus 2018 14:22

quote:
joanwillem schreef op 7 augustus 2018 14:07:
[...]

Lucas even kijken op Finanzen.net , daar staan meerdere persberichten
op van Curetis.

joanb

0.9.29 uhr GWN -News:
Curetis baut geografisiche prasenz weiter aus und wird in Nordafrika und
Lateinafrika aktiv.

joanb

Noob nr1 7 augustus 2018 14:24

quote:
joanwillem schreef op 7 augustus 2018 14:07:
[...]

Lucas even kijken op Finanzen.net , daar staan meerdere persberichten
op van Curetis.

joanb

Bedankt voor de info, zag het zelf op Binck. Weliswaar weer niet bij het algemene nieuws te lezen wel als je naar het aandeel zelf gaat.
Hopelijk terug naar hogere koersstanden toen er overname speculatie inzat

nightrider 7 augustus 2018 14:28

Grootste uitbraak was in januari, van 3.9 euro op 5-01-18 naar 8.5 aangetikt op 10-01-18? zal nu niet zo zijn, maar met de helft ook al meer dan tevreden. Zal moeten lukken, maar fingers crossed. :-)

nightrider 7 augustus 2018 14:29

quote:
MegaTelstar schreef op 7 augustus 2018 14:17:
Volgens mij zijn de trossen al enkele uren geleden losgegooid. Ik ga pas winnen als de koers € 5,70 is gepasseerd, maar goed mijn verlies wordt rap minder... Ik zie een tweede freeze vanmiddag nog wel langskomen en dat met dit weer. It will overboil lijkt mij een betere term voor vandaag.
groet, SuperTelstar

Let's hope for U

Noob nr1 7 augustus 2018 14:39

Benieuwd naar de reactie als de Amerikaanse beurs opengaat. Curetis toch heel actief in de VS

[verwijderd] 7 augustus 2018 15:02

read:https://www.trivano.com/aandeel/curetis-expands-geographic-presence.18913-70817.persbericht

lucas D 7 augustus 2018 16:08

quote:
BLUE001 schreef op 7 augustus 2018 15:02:
read:https://www.trivano.com/aandeel/curetis-expands-geographic-presence.18913-70817.persbericht

Curetis Expands Geographic Presence with Entry into Northern African and Latin American Markets

www.trivano.com

Curetis Expands Geographic Presence with Entry into Northern African and Latin American Markets
New Unyvero distribution partnerships in Egypt, Mexico, and Uruguay
Contractual commitments for 45 Unyvero Systems

Amsterdam, the Netherlands, Holzgerlingen, Germany, and San Diego, CA, USA, August 07, 2018 , 09:30 a.m. EDT - Curetis N.V. (the " Company " and together with its subsidiaries " Curetis "), a developer of next-level molecular diagnostic solutions, today announced exclusive distribution partnerships in Egypt, Mexico, and Uruguay with Future Horizon Scientific, Quimica Valaner S.A. de C.V., and Biko S.A., respectively. The signing of these agreements follows a systematic qualification process conducted by Curetis, which focused on identifying distributors that are experienced in commercializing innovative products for international molecular diagnostics companies.
Each of the three new distribution partners intends to commercialize all five Unyvero Application Cartridges that are currently CE-IVD-marked: HPN for pneumonia, ITI for implant and tissue infections, BCU for bloodstream infections, IAI for intra-abdominal infections, and UTI for urinary tract infections. To establish the installed base of Unyvero Analyzers required to run these cartridge-based tests, the partners have in total committed to purchasing a minimum of 45 Unyvero systems at Curetis' distributor transfer prices over a three-year period. In addition, they have collectively committed to minimum purchases of several thousand Application Cartridges over the term of the agreements.
The agreements will allow Curetis to expand its commercial reach into countries in Northern Africa and Latin America. Initial commercialization activities are expected to begin in the fourth quarter of 2018, following product registrations in the respective countries. The process of registering Unyvero in each of these countries has been initiated following the execution of the respective agreements.

"We are excited to partner with Future Horizon Scientific, Quimica Valaner, and Biko as top-tier distributors that have built strong track records in working with companies like QIAGEN, Bio-Rad, Bruker, and GE Healthcare," said Oliver Schacht, PhD, Chief Executive Officer of Curetis. "Egypt, Mexico, and Uruguay are important countries in the Northern African and Latin American healthcare markets. We anticipate that selling our products through partners in these markets will increasingly contribute to our revenue growth in the coming years. Within just a few months of joining the Company, our new Head of Global Commercial Partner Management, Eneko Goya, has not only negotiated and closed these three agreements, but has also generated a strong pipeline and a very healthy funnel of new distribution partnership opportunities, which we intend to drive to contract closures in the coming months."

"Since its foundation, Quimica Valaner's spirit has been the introduction of reliable and innovative diagnostic technologies to the Mexican market", said Homero Hernandez, CEO of Quimica Valaner. "We are convinced that Curetis' Unyvero solution will resolve important limitations in the diagnosis of infectious diseases in Mexico, creating a direct benefit for the quality-of-life of the Mexican population as well as a sustainable and successful business alliance between Quimica Valaner and Curetis."
To-date, Curetis has signed 16 distribution partnerships covering 29 countries and is planning to expand its distribution network and commercial reach through further partnerships with suitably positioned distributors.
###
About Curetis
Curetis N.V.'s (Euronext: CURE) goal is to become a leading provider of innovative solutions for molecular microbiology diagnostics designed to address the global challenge of detecting severe infectious diseases and identifying antibiotic resistances in hospitalized patients.
Curetis' Unyvero System is a versatile, fast and highly automated molecular diagnostic platform for easy-to-use, cartridge-based solutions for the comprehensive and rapid detection of pathogens and antimicrobial resistance markers in a range of severe infectious disease indications. Results are available within hours, a process that can take days or even weeks if performed with standard diagnostic procedures, thereby facilitating improved patient outcomes, stringent antibiotic stewardship and health-economic benefits. Unyvero in vitro diagnostic (IVD) products are marketed in Europe, the Middle East, Asia and the U.S.

Curetis' wholly owned subsidiary Ares Genetics GmbH offers next-generation solutions for infectious disease diagnostics and therapeutics. The ARES Technology Platform combines what the Company believes to be the most comprehensive database worldwide on the genetics of antimicrobial resistances, ARES db , with advanced bioinformatics and artificial intelligence.
For further information, please visit www.curetis.com and www.ares-genetics.com .
Legal Disclaimer
This document constitutes neither an offer to buy nor an offer to subscribe for securities and neither this document nor any part of it should form the basis of any investment decision in Curetis.
The information contained in this press release has been carefully prepared. However, Curetis bears and assumes no liability of whatever kind for the correctness and completeness of the information provided herein. Curetis does not assume an obligation of whatever kind to update or correct information contained in this press release whether as a result of new information, future events or for other reasons.
This press release includes statements that are, or may be deemed to be, "forward-looking statements." These forward-looking statements can be identified by the use of forward-looking terminology, including the terms "believes," "estimates," "anticipates," "expects," "intends," "targets," "may," "will," or "should" and include statements Curetis makes concerning the intended results of its strategy. By their nature, forward-looking statements involve risks and uncertainties and readers are cautioned that any such forward-looking statements are not guarantees of future performance. Curetis' actual results may differ materially from those predicted by the forward-looking statements. Curetis undertakes no obligation to publicly update or revise forward-looking statements, except as may be required by law.
Contact details
Curetis' Contact Details
Curetis GmbH
Max-Eyth-Str. 42
71088 Holzgerlingen, Germany
Tel. +49 7031 49195-10
pr@curetis.com or ir@curetis.com
www.curetis.com - www.unyvero.com
International Media & Investor Inquiries
akampion
Dr. Ludger Wess / Ines-Regina Buth
Managing Partners
info(@)akampion.com
Tel. +49 40 88 16 59 64
Tel. +49 30 23 63 27 68
U.S. Media & Investor Inquiries
The Ruth Group
Lee Roth
lroth@theruthgroup.com
Tel. +1 646 536 7012

DeZwarteRidder 7 augustus 2018 16:10

Een leuk klinkend flutbericht vlak voor de gruwelijk slechte cijfers.

Diegy 7 augustus 2018 17:55

Morgen ook maar eens instappen. We hebben gezien nog niet zo lang geleden hoe snel de koers van curetis van 5 euro naar 8 euro kan gaan.

lucas D 7 augustus 2018 18:06

Een redelijke slotkoers op berichten die de landelijke pers nog niet heeft geplaatst, mogelijk dat dit morgen wel het geval zal zijn. Zou dat toejuichen, want van grotere bedrijven plaatsen ze alles wat de koers kan beïnvloeden.

Diegy 8 augustus 2018 07:51

Straks ook maar eens instappen. Veel mensen hebben het nieuws van gistermiddag nog niet gezien. Kan straks na opening weer heel hard omhoog gaan.

Diegy 8 augustus 2018 08:52

Paar maanden geleden ging de koers van 5,00 naar 8 euro toe. Gaat de geschiedenis zich herhalen

maurice 1971 8 augustus 2018 09:12

En Diegy zit je vol erin!!!!

DeZwarteRidder 8 augustus 2018 09:14

Dit aandeel staat na de cijfers in een poep en een scheet weer op 3,50 of lager.

2.047 Posts, Pagina: « 1 2 3 4 5 6 ... 75 76 77 78 79 80 81 82 83 84 85 ... 99 100 101 102 103 » | Laatste

Aantal posts per pagina: 20 50 100 | Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met uw e-mailadres en wachtwoord.

Direct naar Forum

Detail

Vertraagd	24 apr 2024 22:00
Koers	0,563
Verschil	-0,050 (-8,16%)
Hoog	0,601
Laag	0,555
Volume	175.679
Volume gemiddeld	1.683.559
Volume gisteren	164.213

OpGen nieuws

Meer ››